Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0019214 (
hepatosplenomegaly
)
4,408
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We present a 6-year-old Chinese boy with
Alagille syndrome
and an interstitial 20p deletion, with a karyotype of 46,XY,der(20)dir ins(7;20)(q11.23;p11.23p12.2 or p12.2p13)mat. He had a peculiar face and suffered from congenital heart disease, growth retardation, severe cholestasis,
hepatosplenomegaly
, and impaired renal function. The karyotype of his mother showed a balanced translocation, 46,XX,dir ins(7;20)(q11.23; p11.23p12.2 or p12.2p13), and her phenotype was normal. His dead elder brother was highly suspected as another victim of
Alagille syndrome
. The findings in the present family suggested that if
Alagille syndrome
is a single gene defect, the putative gene responsible for the syndrome would not be located at the insertion breakpoints but located within the deletion extent.
...
PMID:Alagille syndrome with interstitial 20p deletion derived from maternal ins(7;20). 882 31
Alagille syndrome
is a multisystem disorder classically involving the liver, heart, vertebrae, facial features, and the eyes. In this case report, we document a case of
Alagille syndrome
with an atypical clinical and histopathologic presentation and subsequent identification of a novel JAG1 missense mutation. This case highlights that there may be both atypical clinical and pathologic findings in mutation-proven
Alagille syndrome
and that the diagnosis of
Alagille syndrome
should be considered in cases of ongoing bile duct damage in the setting of early-onset jaundice, cholestasis,
hepatosplenomegaly
, posterior embryotoxon in the eyes, and butterfly vertebrae.
...
PMID:An Atypical Presentation of Alagille Syndrome. 2918 43